This bill amends the New Mexico Controlled Substances Act to align the scheduling of crystalline polymorph psilocybin with federal law. Specifically, it introduces a new provision stating that upon the rescheduling of crystalline polymorph psilocybin by the United States Food and Drug Administration, it will be automatically scheduled and listed in accordance with federal regulations. This insertion aims to ensure that state law remains consistent with federal law regarding the control of this substance.

Additionally, the bill modifies the existing Schedule I controlled substances list to include a provision that psilocybin will be included in Schedule I, but only immediately upon its rescheduling by the FDA. This change reflects a recognition of the evolving legal landscape surrounding psilocybin and aims to facilitate its regulation in a manner that is responsive to federal actions. The bill does not remove any existing substances from the Schedule I list but rather adds clarity to the status of psilocybin in relation to federal law.

Statutes affected:
introduced version: 30-31-3, 30-31-6